BioVaxys Acquires IMV’s Immunotherapy Tech for Growth
BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...
- Latest
- Trending
BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...
Big Lots is expected to meet previous guidance for sales, margin, expenses, and inventory. The company generated cash from inventory ...
Wealthy crypto investors are moving $350 million in digital assets, mainly in Bitcoin and Ethereum. This suggests high activity and ...
The US federal budget deficit narrows in January, but concerns remain as it has expanded in the first four months ...
Stocks climb in midday trading as most sectors trend higher, led by gains in consumer discretionary, process industries, and commercial ...
The latest consumer sentiment survey by the New York Federal Reserve reveals stable inflation expectations and optimism in the U.S. ...
Federated Hermes Premier Municipal Income Fund declares tax-free dividend distribution, solidifying its position as a reliable investment partner and attracting ...
Arthur J. Gallagher & Co. expands its global reach with the acquisition of Simply-Communicate Ltd, aiming to strengthen its capabilities ...
NRx Pharmaceuticals receives a $5 million milestone payment for the development of its drug candidate NRX-101, supporting its progress through ...
MetLife strengthens enterprise data solutions with the appointment of Michelleta Razon as Head of Data Enablement, enhancing decision-making and innovation. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.